IEİlKer Erden

İlKer Erden

*This is an algorithmically generated author record based on publicly available information.

İlKer Erden has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Investigation of serum and saliva dermcidin levels in patients with recurrent aphthous stomatitis and dermcidin analysis in salivary gland

    by Betül Demi̇r, Demet Çi̇çEk, İlKer Erden, Süleyman Aydin, Özlem Üçer, Tuncay Kuloğlu, Mehmet Kalayci, Meltem Yardim, Esma İnan Yüksel

    Objective Recurrent aphthous stomatitis (RAS) is a common self-limiting oral mucosa disease. In this study, it was aimed to determine the dermcidin level in the serum and saliva of patients with RAS, the presence of dermcidin in the salivary gland and its role in the pathogenesis of RAS. Methods Thirty-one patients presenting with RAS and 30 control subjects participated in this study. Dermcidin levels in serum and saliva of patients and control group were studied in accordance with the working procedures specified in the catalogs of the human dermcidin ELISA kit. The presence of dermcidin in salivary glands was assessed by immunohistochemical analysis. Results A statistically significant difference was found when the mean salivary dermcidin levels (105.80 ± 80.14 ng/mL) of the RAS patients were compared with the mean salivary dermcidin levels (456.13 ± 354.59 ng/mL) of the control group (P=0.000). There was no statistically significant difference between the mean serum dermcidin levels (316.41 ± 784.55 ng/mL) of the RAS patient and those of (130.65 ± 179.75 ng/mL) the control group. Dermcidin immunoreactivity was observed in the parotid gland, submandibular gland and interlobular striated ducts. Conclusion The findings in this study showed that striated cells in salivary gland synthesized dermcidin. Low levels of dermcidin with antimicrobial properties in saliva were considered as a predisposing factor for RAS.